Introducing CHILD-BRIGHT: Get involved in our patient-oriented research network

Last modified by Ann Watkins on 2017/06/30 18:05

Get to know CHILD-BRIGHT, an innovative pan-Canadian network that aims to improve life outcomes for children with brain-based developmental disabilities and their families.

Join Dr. Annette Majnemer, along with Dr. Steven Miller, Dr. Dan Goldowitz, Frank Gavin and Dr. Keiko Shikako-Thomas as they share an overview of the network and how it is currently supported by patient-oriented research, patient-oriented training, citizen engagement and knowledge translation programs.

From this presentation, participants should come to appreciate:

  • How our research aims to improve child health and development, enhance patient/family experience, and develop cost-effective strategies.
  • How patients, families, researchers, clinicians, policy makers, and other key stakeholders are working together to (1) create novel interventions to optimize development, (2) identify better ways to deliver responsive and supportive services, and (3) improve systems, knowledge, and practices to ensure better outcomes for these children and their families.
  • How CAPHC’s international community of child and youth healthcare practitioners, patients, families, researchers and other stakeholders can impact our decisions, activities and events. Your voice is the one that matters.

Save the date!

childbrainnetwork.png

Want to know more about our work? Visit www.child-bright.ca and follow our social media pages on Twitter https://twitter.com/ChildBrightNet/ and Facebook https://www.facebook.com/childbrightnetwork/

Click here to download the presentation slides.

Click here to take the CHILD-Bright Network webinar feedback survey.

Dr. Annette Majnemer
CHILD-BRIGHT Network Director & Principal Investigator

Dr. Steven Miller
CHILD-BRIGHT Co-Director & Principal Investigator

Dr. Dan Goldowitz
CHILD-BRIGHT Co-Director

Frank Gavin
Founder, the Canadian Family Advisory Network (CFAN)
CHILD-BRIGHT Patient Representative

Dr. Keiko Shikako-Thomas
Principal Investigator

Tags:
Created by Ann Watkins on 2017/05/29 20:40